Similar articles

• Testing low-risk patients for suspected pulmonary embolism: a decision analysis.

  Lessler AL, Isserman JA, Agarwal R, Palevsky HI, Pines JM. Lessler AL, et al. Ann Emerg Med. 2010 Apr;55(4):316-326.e1. doi: 10.1016/j.annemergmed.2009.12.001. Epub 2010 Jan 12. Ann Emerg Med. 2010. PMID: 20061065
• The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.

  Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, Anderson J, Rodger MA. Wells PS, et al. Arch Intern Med. 2003 Apr 28;163(8):917-20. doi: 10.1001/archinte.163.8.917. Arch Intern Med. 2003. PMID: 12719200
• Are we ready to start outpatient treatment for pulmonary embolism?

  Meyer G. Meyer G. Thromb Haemost. 2008 Nov;100(5):736-7. Thromb Haemost. 2008. PMID: 18989512 No abstract available.
• Does low molecular weight heparin cause less bleeding?

  Thomas DP. Thomas DP. Thromb Haemost. 1997 Dec;78(6):1422-5. Thromb Haemost. 1997. PMID: 9423787 Review. No abstract available.
• Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.

  Tran H, McRae S, Ginsberg J. Tran H, et al. Clin Geriatr Med. 2006 Feb;22(1):113-34, ix. doi: 10.1016/j.cger.2005.09.004. Clin Geriatr Med. 2006. PMID: 16377470 Review.